Literature DB >> 6645121

Maltotriose and maltotetraose excreted in urine following intravenous administration of maltose to human volunteers.

O Yuge, M Morio, T Fukui, K Fujii, H Kikuchi, S Takahashi.   

Abstract

To determine the extent of maltose excreted into the urine, sugar substances present in the urine following intravenous infusion of maltose were analyzed. Maltose, glucose, maltotriose and maltotetraose in the urine were detected by gas chromatography and identified by mass spectrometric analysis. The total amounts of sugar substances excreted after 10 per cent maltose solution given at three different infusion rates were calculated. The excreted amounts of maltotriose and maltotetraose increased in a dose and time dependent manner. As these compounds were not detected in the plasma either during or after the administration of maltose, the kidney probably plays a role in the biosynthesis of maltotriose and maltotetraose. Studies on the organ homogenates of the rabbit showed that the enzyme activity for the biosynthesis of maltotriose from maltose was mainly in the kidney. The glucose excreted into the urine probably originates from maltose catalyzed to glucose, mainly by the action of kidney maltase. As the rate of excretion of sugar substances increased in a dose dependent manner, adequate infusion rates of maltose should be less than 0.5 g/kg/hour.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6645121     DOI: 10.1007/BF02469510

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  3 in total

1.  Synthesis of oligosaccharides from maltose by rat liver.

Authors:  K V GIRI; A NAGABHUSHANAM; V N NIGAM; B BELAVADI
Journal:  Science       Date:  1955-06-24       Impact factor: 47.728

2.  The effect of insulin on the metabolism of parenteral maltose in man.

Authors:  E A Young; A Drummond; D A Cool; L A Cioletti; M Crain; J B Traylor; E Weser
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

3.  Metabolism of circulating disaccharides in man and the rat.

Authors:  E Weser; M H Sleisenger
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.